General Biologicals Balance Sheet Health
Financial Health criteria checks 3/6
General Biologicals has a total shareholder equity of NT$598.0M and total debt of NT$5.9M, which brings its debt-to-equity ratio to 1%. Its total assets and total liabilities are NT$1.9B and NT$1.3B respectively.
Key information
1.0%
Debt to equity ratio
NT$5.92m
Debt
| Interest coverage ratio | n/a |
| Cash | NT$206.19m |
| Equity | NT$598.04m |
| Total liabilities | NT$1.25b |
| Total assets | NT$1.85b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 4117's short term assets (NT$388.7M) exceed its short term liabilities (NT$336.8M).
Long Term Liabilities: 4117's short term assets (NT$388.7M) do not cover its long term liabilities (NT$916.1M).
Debt to Equity History and Analysis
Debt Level: 4117 has more cash than its total debt.
Reducing Debt: 4117's debt to equity ratio has reduced from 54.2% to 1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 4117 has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 4117 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.